Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · SGU

Neurovascular Liquid Embolic Agent

Arterial occlusion of the middle meningeal artery for treatment of symptomatic subdural hematoma.

Product / regulatory recordCompanyPathwayDecision dateSource
Balt USA, LLCPMA supplementOct 16, 2026FDA
Balt USA, LLCPMA supplementSep 9, 2026FDA
Balt USA, LLCPMA approvalJan 30, 2026FDA
Source information

Follow the FDA links to view the original records.

All device categories